Multiple sclerosis (MS) is a demyelinating autoimmune disease affecting the central nervous system, characterized by immune attacks on myelin that disrupt neuron communication and lead to various sensory, motor, and cognitive problems. Affecting approximately 2.5 million people, predominantly women, MS has various forms, with relapsing-remitting being the most common. Treatment options include physical therapy, corticosteroids, immunosuppressants, and emerging therapies like deep brain stimulation.